Abstract | PURPOSE: METHODS: A rapidly dissolving porous particle formulation of paclitaxel (AI-850) was created using spray drying. AI-850 was compared to Taxol following intravenous administration in a rat pharmacokinetic study, a rat tissue distribution study, and a human xenograft mammary tumor (MDA-MB-435) model in nude mice. RESULTS: The volume of distribution and clearance for paclitaxel following intravenous bolus administration of AI-850 were 7-fold and 4-fold greater, respectively, than following intravenous bolus administration of Taxol. There were no significant differences between AI-850 and Taxol in tissue concentrations and tissue area under the curve (AUC) for the tissues examined. Nude mice implanted with mammary tumors showed improved tolerance of AI-850, enabling higher administrable does of paclitaxel, which resulted in improved efficacy as compared to Taxol administered at its maximum tolerated dose (MTD). CONCLUSIONS: The pharmacokinetic data indicate that paclitaxel in AI-850 has more rapid partitioning from the bloodstream into the tissue compartments than paclitaxel in Taxol. AI-850, administered as an intravenous injection, has been shown to have improved tolerance in rats and mice and improved efficacy in a tumor model in mice when compared to Taxol.
|
Authors | Julie A Straub, Donald E Chickering, Jonathan C Lovely, Huimin Zhang, Bhavdeep Shah, William R Waud, Howard Bernstein |
Journal | Pharmaceutical research
(Pharm Res)
Vol. 22
Issue 3
Pg. 347-55
(Mar 2005)
ISSN: 0724-8741 [Print] United States |
PMID | 15835739
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Animals
- Chemistry, Pharmaceutical
- Drug Delivery Systems
(methods)
- Female
- Humans
- Hydrophobic and Hydrophilic Interactions
- Infusions, Intravenous
- Male
- Mice
- Mice, Nude
- Paclitaxel
(administration & dosage, metabolism)
- Particle Size
- Porosity
- Rats
- Rats, Sprague-Dawley
|